Simultaneous Treatment of Moderate-to-Severe Horizontal Frontalis Lines, Glabellar Lines, and Lateral Canthal Lines wtih OnabotulinumtoxinA from the Subject's Perspective: Patient-Reported Satisfaction and Impact Outcomes from a Phase 3 Double-Blind Study

Main Article Content

Steven Dayan
Patricia Ogilvie
Alexander Z Rivkin
Steven G Yoelin
Julie Garcia
Ilia L Ferrusi

Keywords

Horizontal Frontalis Lines, Glabellar Lines, OnabotulinumtoxinA, Cosmetic, Randomized trial

Abstract

Abstract Not Available
Study supported by Allergan.